Impact of Body Mass Index on Surgical and Oncological Outcomes in Laparoscopic Total Mesorectal Excision for Locally Advanced Rectal Cancer after Neoadjuvant 5-Fluorouracil-Based Chemoradiotherapy
Aims. To evaluate the impact of body mass index (BMI) on the surgical outcome of laparoscopic total mesorectal excision (laTME) for locally advanced rectal cancer (LARC, clinically staged as UICC stage II/III) after neoadjuvant chemoradiotherapy (nCRT). Methods. 312 LARC patients undergoing laTME af...
Main Authors: | Yanwu Sun, Pan Chi |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2017-01-01
|
Series: | Gastroenterology Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2017/1509140 |
Similar Items
-
Oncological outcomes of robotic-assisted total mesorectal excision after neoadjuvant concurrent chemoradiotherapy in patients with rectal cancer
by: Po-Jung Chen, et al.
Published: (2021-07-01) -
Comparison of short-term efficacy of transanal total mesorectal excision and laparoscopic total mesorectal excision in low rectal cancer
by: Jingqing Ren, et al.
Published: (2021-01-01) -
Impact of neoadjuvant treatment on total mesorectal excision for ultra-low rectal cancers
by: Fan Joe FM, et al.
Published: (2010-03-01) -
Neoadjuvant concurrent chemoradiotherapy followed by transanal total mesorectal excision assisted by single-port laparoscopic surgery for low-lying rectal adenocarcinoma: a single center study
by: Yen-Jung Lu, et al.
Published: (2020-08-01) -
Total mesorectal excision for the treatment of rectal cancer
by: Ali Zedan, et al.
Published: (2015-12-01)